Benign and malignant proliferation in idiopathic nephrotic syndrome: a French cohort study

Pediatr Nephrol. 2022 Aug;37(8):1837-1843. doi: 10.1007/s00467-021-05386-0. Epub 2022 Jan 10.

Abstract

Background: There seems to be a possible link between nephrotic syndrome (NS) and lymphoproliferative syndrome, but it remains poorly understood.

Methods: This multicentric and retrospective study focuses on children, who developed idiopathic NS and malignant or benign proliferation between 2000 and 2021.

Results: Eleven patients were included, with a median age of 4 years. Only one had a steroid-resistant nephrotic syndrome (SRNS). The maintenance therapy before the proliferation was in majority tacrolimus or mycophenolate mofetil (MMF), but three patients did not receive treatments. The proliferation was mainly a Hodgkin's lymphoma (45%) or a lymphoproliferative disease (36%), in a median time after the NS of two years. Viruses were found in seven cases (EBV in five cases and HHV-8 in two).

Conclusion: The association between proliferative syndrome and idiopathic NS may not be fortuitous, possibly with a common lymphocytic disturbance. Genetic analyses could improve the comprehension of these manifestations in the future. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keywords: Children; Lymphoproliferation; Nephrotic syndrome; Smooth muscle tumors.

Publication types

  • Multicenter Study

MeSH terms

  • Cell Proliferation
  • Child, Preschool
  • Cohort Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mycophenolic Acid
  • Nephrosis, Lipoid*
  • Nephrotic Syndrome* / complications
  • Nephrotic Syndrome* / drug therapy
  • Remission Induction
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid

Supplementary concepts

  • Nephrosis, congenital